• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

打破科学壁垒,实现合作共赢。

Creating collaboration by breaking down scientific barriers.

机构信息

Quantitative Biosciences Institute (QBI), San Francisco, CA 94158, USA; QBI COVID-19 Research Group (QCRG), University of California, San Francisco, San Francisco, CA 94158, USA; School of Pharmacy, University of California, San Francisco, San Francisco, CA 94158, USA.

Quantitative Biosciences Institute (QBI), San Francisco, CA 94158, USA; QBI COVID-19 Research Group (QCRG), University of California, San Francisco, San Francisco, CA 94158, USA; School of Pharmacy, University of California, San Francisco, San Francisco, CA 94158, USA; David Gladstone Institutes, San Francisco, CA 94158, USA; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

出版信息

Cell. 2021 Apr 29;184(9):2271-2275. doi: 10.1016/j.cell.2021.02.022. Epub 2021 Mar 24.

DOI:10.1016/j.cell.2021.02.022
PMID:33765441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8630979/
Abstract

The scientific world rewards the individual while often discouraging collaboration. However, times of crisis show us how much more we can accomplish when we work together. Here, we describe our approach to breaking down silos and fostering global collaborations and share the lessons we have learned, especially pertaining to research on SARS-CoV-2.

摘要

科学界奖励个人,却常常阻碍合作。然而,危机时刻向我们展示了,当我们共同努力时,可以取得多大的成就。在这里,我们描述了打破隔阂、促进全球合作的方法,并分享了我们从中吸取的经验教训,特别是与 SARS-CoV-2 研究相关的经验教训。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/797d/9050202/586ebadb0a28/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/797d/9050202/586ebadb0a28/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/797d/9050202/586ebadb0a28/gr1_lrg.jpg

相似文献

1
Creating collaboration by breaking down scientific barriers.打破科学壁垒,实现合作共赢。
Cell. 2021 Apr 29;184(9):2271-2275. doi: 10.1016/j.cell.2021.02.022. Epub 2021 Mar 24.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
4
The Lived Experience of Autistic Adults in Employment: A Systematic Search and Synthesis.成年自闭症患者的就业生活经历:系统检索与综述
Autism Adulthood. 2024 Dec 2;6(4):495-509. doi: 10.1089/aut.2022.0114. eCollection 2024 Dec.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
Interventions for palliative symptom control in COVID-19 patients.干预措施以控制 COVID-19 患者的姑息症状。
Cochrane Database Syst Rev. 2021 Aug 23;8(8):CD015061. doi: 10.1002/14651858.CD015061.
7
Patient buy-in to social prescribing through link workers as part of person-centred care: a realist evaluation.患者通过联络人员接受社会处方作为以患者为中心的护理的一部分:一项现实主义评价。
Health Soc Care Deliv Res. 2024 Sep 25:1-17. doi: 10.3310/ETND8254.
8
Application of a high-resolution melt assay for monitoring SARS-CoV-2 variants in Burkina Faso and Kenya.高分辨率熔解分析在布基纳法索和肯尼亚监测严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体中的应用。
mSphere. 2025 Jun 25;10(6):e0002725. doi: 10.1128/msphere.00027-25. Epub 2025 May 29.
9
Effects of experiencing the COVID-19 pandemic on optimistically biased belief updating.经历新冠疫情对乐观偏差信念更新的影响。
Elife. 2025 Jun 30;13:RP101157. doi: 10.7554/eLife.101157.
10
Fabricating mice and dementia: opening up relations in multi-species research制造小鼠与痴呆症:开启多物种研究中的关联

引用本文的文献

1
Oxygen-Sensitive Optical Nanosensors: Current Advances and Future Perspectives.氧敏感光学纳米传感器:当前进展与未来展望
ACS Sens. 2025 May 23;10(5):3194-3206. doi: 10.1021/acssensors.5c00180. Epub 2025 Apr 24.
2
Radical Collaboration: Reimagining Cancer Team Science.激进协作:重新构想癌症团队科学。
Cancer Discov. 2024 Apr 4;14(4):563-568. doi: 10.1158/2159-8290.CD-23-1496.
3
Emerging advances in biosecurity to underpin human, animal, plant, and ecosystem health.生物安全领域的新进展为人类、动物、植物和生态系统健康提供支撑。

本文引用的文献

1
Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking.通过晶体筛选和计算对接鉴定到 SARS-CoV-2 的 Nsp3 结构域的片段结合。
Sci Adv. 2021 Apr 14;7(16). doi: 10.1126/sciadv.abf8711. Print 2021 Apr.
2
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A.普里替定通过靶向宿主蛋白 eEF1A 对 SARS-CoV-2 具有强大的临床前疗效。
Science. 2021 Feb 26;371(6532):926-931. doi: 10.1126/science.abf4058. Epub 2021 Jan 25.
3
An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike.
iScience. 2023 Jul 31;26(9):107462. doi: 10.1016/j.isci.2023.107462. eCollection 2023 Sep 15.
4
The scientific director: A complimentary model for academic leadership.科学主任:学术领导力的补充模式。
Cell. 2023 Jul 6;186(14):2951-2955. doi: 10.1016/j.cell.2023.05.036.
5
Lessons learned for pandemic preparedness: A collaborative network is imperative.为大流行做准备的经验教训:合作网络是必不可少的。
Cell Host Microbe. 2023 Jun 14;31(6):843-846. doi: 10.1016/j.chom.2023.05.008.
6
Be in it for the Long Haul: A Commentary on Human Tissue Recovery Initiatives.着眼长远:人类组织回收倡议述评。
J Pain. 2022 Oct;23(10):1646-1650. doi: 10.1016/j.jpain.2022.04.009. Epub 2022 Apr 30.
7
Target Discovery for Host-Directed Antiviral Therapies: Application of Proteomics Approaches.宿主导向抗病毒疗法的靶点发现:蛋白质组学方法的应用
mSystems. 2021 Oct 26;6(5):e0038821. doi: 10.1128/mSystems.00388-21. Epub 2021 Sep 14.
8
How the COVID pandemic is changing global science collaborations.新冠疫情如何改变全球科学合作。
Nature. 2021 Jun;594(7863):316-319. doi: 10.1038/d41586-021-01570-2.
一种超强效的合成纳米抗体通过稳定无活性的 Spike 来中和 SARS-CoV-2。
Science. 2020 Dec 18;370(6523):1473-1479. doi: 10.1126/science.abe3255. Epub 2020 Nov 5.
4
Bi-paratopic and multivalent VH domains block ACE2 binding and neutralize SARS-CoV-2.双对偶和多价 VH 结构域阻断 ACE2 结合并中和 SARS-CoV-2。
Nat Chem Biol. 2021 Jan;17(1):113-121. doi: 10.1038/s41589-020-00679-1. Epub 2020 Oct 20.
5
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.比较宿主-冠状病毒蛋白相互作用网络揭示泛病毒疾病机制。
Science. 2020 Dec 4;370(6521). doi: 10.1126/science.abe9403. Epub 2020 Oct 15.
6
The Global Phosphorylation Landscape of SARS-CoV-2 Infection.新冠病毒感染的全球磷酸化组景观。
Cell. 2020 Aug 6;182(3):685-712.e19. doi: 10.1016/j.cell.2020.06.034. Epub 2020 Jun 28.
7
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.一种 SARS-CoV-2 蛋白相互作用图谱揭示了药物再利用的靶标。
Nature. 2020 Jul;583(7816):459-468. doi: 10.1038/s41586-020-2286-9. Epub 2020 Apr 30.